Table 1.

Characteristics of CMV-seropositive kidney transplant recipients included in the study.

Characteristics	All (n = 64)
Age (years; mean ± SD [min; max])	54.4 ± 13.5 [25; 78]
Gender, n (%)
Female	22 (34.4%)
Male	42 (65.6%)
1st transplantation, n (%)	52 (81.3%)
CMV serology status, n (%)
D+/R+	28 (43.8%)
D−/R+	36 (56.3%)
Antiviral prophylaxis treatment, n (%)	45 (70.3%)
Valganciclovir/Ganciclovir	43 (95.6%)
Valaciclovir	2 (4.4%)
Duration of antiviral prophylaxis (days; median [IQR])	103.5 [86; 147.5]

SD, standard deviation; D, donor; R, recipient; and IQR, interquartile range.